AMANDA GUNN: Open Payments
NPI 1528488442 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,019 in 44 payments from 11 companies in 2025. Trend: 2023 $2,528 · 2024 $671 · 2025 $1,019
Food & beverage: $1,019
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $414 |
| GlaxoSmithKline, LLC. | 14 | $260 |
| Optinose US, Inc. | 5 | $97 |
| Hill Dermaceuticals, Inc. | 1 | $60 |
| AERIN MEDICAL INC. | 3 | $51 |
| Urgo Medical North America, LLC | 1 | $31 |
| Smith+Nephew, Inc. | 1 | $30 |
| Boston Scientific Corporation | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Solventum Corporation | 1 | $19 |
Products named: DUPIXENT, NUCALA, Xhance, Tolak, VIVAER STYLUS, VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP, COLLAGENASE SANTYL, General - Pain Management.
Industry payments across AZ — which companies pay providers there.
